06/04/2026
**𝗙𝗶𝗿𝘀𝘁 𝗶𝗻 𝗖𝗮𝗹𝗶𝗳𝗼𝗿𝗻𝗶𝗮.**
Berg-Feinfield Vision Correction is proud to share an exciting milestone in corneal care: our team has completed the first corneal cross-linking procedure in California using FDA-approved Epioxa™.
Epioxa™ is the first FDA-approved epithelium-on, oxygen-enriched corneal cross-linking therapy — an advanced treatment option designed to help strengthen the cornea in appropriate patients with conditions such as keratoconus and progressive corneal thinning.
We are honored to continue bringing innovative treatment options to the patients we serve.
To learn more or schedule a consultation, call 866-2-SEE FAR or visit bergfeinfield.com.